Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 3Breast Neoplasms 3Prostatic Neoplasms 2Neuroblastoma 2Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia 2Endometrial Neoplasms 2Congenital Abnormalities 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Pleuropulmonary blastoma 1Papillomavirus Infections 1Pain 1Neurofibrosarcoma 1Neoplasms 1Myeloproliferative Syndrome, Transient 1Meningioma 1Malignant mesenchymal tumor 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Liposarcoma 1Leukemia, Eosinophilic, Acute 1

Interventions

Magnetic Resonance Spectroscopy 4Doxorubicin 4Cyclophosphamide 4Vincristine 3Topotecan 3Stem Cell Transplantation 3Specimen Handling 3Radiation 3Platinum 3Melphalan 3Isotretinoin 3Congresses as Topic 3Cisplatin 3Busulfan 3Biopsy 33-Iodobenzylguanidine 31,2-diaminocyclohexaneplatinum II citrate 3sargramostim 2etoposide phosphate 2dinutuximab 2Etoposide 2Colony-Stimulating Factors 2Carboplatin 2lorlatinib 1Watchful Waiting 1Thiotepa 1Temozolomide 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Ganglioneuroblastoma × Observation × Clear all
NCT02176967 2026-05-05

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Children's Oncology Group

Phase 3 Active not recruiting
621 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡